Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01411020
Other study ID # Ricardo Fuentes
Secondary ID Hernan Muñoz
Status Completed
Phase Phase 4
First received August 3, 2011
Last updated May 14, 2013
Start date October 2009
Est. completion date November 2012

Study information

Verified date August 2009
Source Pontificia Universidad Catolica de Chile
Contact n/a
Is FDA regulated No
Health authority Chile: Institutional Review Board
Study type Interventional

Clinical Trial Summary

The purpose of this study is to determine a effect-site concentration of propofol in children 3 to 11 years effective to make a induction of general anesthesia.


Recruitment information / eligibility

Status Completed
Enrollment 60
Est. completion date November 2012
Est. primary completion date August 2012
Accepts healthy volunteers No
Gender Both
Age group 3 Years to 11 Years
Eligibility Inclusion Criteria:

- obtained informed consent

- children between 3 and 11 years

- healthy

- elective surgery under general anesthesia

- no premedication

Exclusion Criteria:

- body mass index for age > 95th percentile

- chronic or acute intake of any sedative drug

- any known adverse effect to the study drugs

Study Design

Allocation: Randomized, Endpoint Classification: Pharmacokinetics/Dynamics Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Treatment


Related Conditions & MeSH terms

  • Children Under General Anesthesia

Intervention

Procedure:
endotracheal intubation
to perform endotracheal intubation if number of bispectral index (BIS) is 40-60,

Locations

Country Name City State
Chile Hospital Clinico Universidad Catolica Santiago Metropolitana

Sponsors (1)

Lead Sponsor Collaborator
Pontificia Universidad Catolica de Chile

Country where clinical trial is conducted

Chile, 

References & Publications (1)

Muñoz HR, León PJ, Fuentes RS, Echevarría GC, Cortínez LI. Prospective evaluation of the time to peak effect of propofol to target the effect site in children. Acta Anaesthesiol Scand. 2009 Aug;53(7):883-90. doi: 10.1111/j.1399-6576.2009.01995.x. Epub 2009 Jun 3. — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary dose of propofol to obtain a dose appropriate of propofol in induction of anesthesia two days (duration of hospitalization) Yes
See also
  Status Clinical Trial Phase
Recruiting NCT02940938 - Study on Changes of Pulse Oximeter Plethysmographic Amplitude Induced by Respiration in Pediatric Patients N/A